1. Home
  2. ADAM vs WVE Comparison

ADAM vs WVE Comparison

Compare ADAM & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adamas Trust Inc.

ADAM

Adamas Trust Inc.

SELL

Current Price

$7.64

Market Cap

673.2M

Sector

Technology

ML Signal

SELL

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$3.17

Market Cap

744.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAM
WVE
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
673.2M
744.8M
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
ADAM
WVE
Price
$7.64
$3.17
Analyst Decision
Hold
Strong Buy
Analyst Count
7
19
Target Price
$12.04
★ $18.06
AVG Volume (30 Days)
1.2M
★ 2.9M
Earning Date
10-28-2026
11-09-2026
Dividend Yield
★ 14.08%
N/A
EPS Growth
★ 196.49
N/A
EPS
★ 0.87
N/A
Revenue
N/A
★ $3,704,000.00
Revenue This Year
N/A
$19.21
Revenue Next Year
$5.45
N/A
P/E Ratio
$8.82
★ N/A
Revenue Growth
N/A
★ 149.43
52 Week Low
$6.45
$3.27
52 Week High
$10.36
$21.73

Technical Indicators

Market Signals
Indicator
ADAM
WVE
Relative Strength Index (RSI) 22.02 20.10
Support Level $7.05 N/A
Resistance Level $7.80 $6.33
Average True Range (ATR) 0.22 0.19
MACD 0.00 -0.02
Stochastic Oscillator 23.08 2.53

Price Performance

Historical Comparison
ADAM
WVE

About ADAM Adamas Trust Inc.

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: